Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Next Science Acne Cream in mild to moderate facial acne
NCT03106766Phase 1Terminated
- Sponsor
- Next Science
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Next Science Acne Cream in acne vulgaris (2 arms), sponsored by Next Science. Primary endpoint: Reduction in Lesion Count at 6 months. Started Mar 2017; status: terminated.
02
Drugs
Next Science Acne Cream
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03106766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106766.